SarbjitSinghSainiMD

Allergy & Immunology • Baltimore, MD

Asthma & Allergic Conditions

Professor of Medicine, Johns Hopkins University School of Medicine Director, Allergy and Immunology Fellowship Program

Join to view full profile

Dr. Saini is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Saini's full profile

Already have an account?

Office
5501 Hopkins Bayview Circle
Allergy & Asthma Center, 2nd Floor
Baltimore, MD 21224
Phone+1 410-550-2300

Fax+1 410-550-3256

Summary

Dr. Sarbjit Saini is an allergist/immunologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. He received his medical degree from The Ohio State University College of Medicine and has been in practice 26 years.

Education & Training

Johns Hopkins UniversityFellowship, Allergy and Immunology, 1994 - 1997
University of MichiganResidency, Internal Medicine, 1991 - 1994
Ohio State University College of MedicineClass of 1991

Certifications & Licensure

FL State Medical License 2020 - Present
MD State Medical License 1995 - 2025
MI State Medical License 1993 - 1997
American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Effect of Anti-IgE in Chronic Urticaria Start of enrollment: 2004 Nov 01
Completed
Phase 2
Omalizumab in the Treatment of Peanut Allergy Start of enrollment: 2009 Jul 01
Completed
Phase 2
The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge Start of enrollment: 2009 Oct 01
Completed
Phase 2
Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils Start of enrollment: 2013 Feb 01
Completed
Phase 4
Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines Start of enrollment: 2014 Jan 01
Completed
Phase 2
Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU) Start of enrollment: 2017 Oct 06
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

394 citations
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
Torsten Zuberbier, Amir Hamzah Abdul Latiff, Mohamed Abuzakouk, S. Aquilina, Riccardo Asero
Allergy. 2021-10-20
64 citations
Chronic Spontaneous Urticaria: The Devil's Itch.
Sarbjit S. Saini, Allen P. Kaplan
The Journal of Allergy and Clinical Immunology. in Practice. 2018-07-01
111 citations
Definition, aims, and implementation of GA(2) LEN Urticaria Centers of Reference and Excellence
Marcus Maurer, Martin Metz, Carsten Bindslev-Jensen, Jean Bousquet, Giorgio Walter Canonica
Allergy. 2016-08-01

Other

Chronic urticaria: Clinical manifestations, diagnosis, pathogenesis, and natural history
Saini S
http://www.uptodate.com/contents/chronic-urticaria-clinical-manifestations-diagnosis-pathogenesis-an
UpToDate, Wolters Kluwer Health - 2013-01-28

Press Mentions

Novel BTK Inhibitor for Chronic Hives Wins in Phase III TrialNovember 16th, 2023

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/sarbjit-saini